Prihlásiť sa Zaregistrujte sa zadarmo

Výnosy Q/Q spoločnosti AMAG Pharmaceuticals

Aká je hodnota metriky Výnosy Q/Q spoločnosti AMAG Pharmaceuticals?

Hodnota metriky Výnosy Q/Q spoločnosti AMAG Pharmaceuticals, Inc. je 10.67%

Aká je definícia metriky Výnosy Q/Q?

Štvrťročný rast výnosov (Revenue Q/Q) z roku na rok je zvýšenie príjmov firmy v porovnaní s výsledkami v korešpondujúcom štvrťroku minulého roku a vyjadreného v percentách.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Výnosy Q/Q spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou AMAG Pharmaceuticals

Čomu sa venuje spoločnosť AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Firmy s metrikou výnosy q/q podobnou spoločnosti AMAG Pharmaceuticals